Assessment of the NIPE in Very Premature Infant Ventilated and Sedated in Neonatal Reanimation.

Launched by UNIVERSITY HOSPITAL, LILLE · Jan 24, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a tool called the Newborn Infant Parasympathetic Evaluation (NIPE), which helps measure how well an infant's nervous system is working by looking at changes in their heart rate. The goal is to see if this tool can effectively assess pain and discomfort in very premature babies who are being cared for in a neonatal intensive care unit (NICU) while they are on a ventilator and sedated.

To be eligible for this study, babies must be born very prematurely (before 34 weeks of pregnancy) and be 7 days old or younger. They also need to be receiving treatment in the NICU and require sedation and mechanical breathing support. Parents considering participation can expect that their baby's heart rate will be monitored using the NIPE to help determine if it is a good way to understand and measure their pain during critical care. It's important to note that if a baby has certain conditions or if a parent does not wish to participate, they will not be included in the study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Infant born very premature before 34 weeks of amenorrhoea + 0 day
• • Age ≤ 7 days
• • Admitted in neonatal reanimation
• • Sedated, intubated, ventilated
• Exclusion Criteria:
• • High frequency oscillation ventilation
• • Heart rate non sinusal
• • Inotropes and atropine
• • Opposition from the guardian of parental authority
• • Difficulty of comprehension or communication making the parental information impossible